Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Cancers”

805 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 805 results

Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Early research (Phase 1)Not Yet RecruitingNCT06647329
What this trial is testing

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

Who this might be right for
CAR-T Cell TherapyLymphomas
Mingzhi Zhang 30
Not applicableUnknownNCT02612402
What this trial is testing

Effect of Smartphone App on Activity

Who this might be right for
Diabetes Type 2Hematologic Malignancy
Rambam Health Care Campus 270
Large-scale testing (Phase 3)Study completedNCT02730299
What this trial is testing

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)+4 more
Gamida Cell ltd 125
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT02452099
What this trial is testing

Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.

Who this might be right for
Multiple MyelomaLymphomasLeukemias
Maria Sklodowska-Curie National Research Institute of Oncology 150
Not applicableNot Yet RecruitingNCT06402175
What this trial is testing

Characteristics and Outcomes of Patients With Hematological Malignancies

Who this might be right for
Haematologic Neoplasm
Assiut University 100
Not applicableLooking for participantsNCT06253338
What this trial is testing

Optimization of Radiation Protection Through Genomic Analyses

Who this might be right for
DNACancerRadiation
University Hospital, Essen 30
Large-scale testing (Phase 3)UnknownNCT00883961
What this trial is testing

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Who this might be right for
Hematological Disease
Charite University, Berlin, Germany 60
Early research (Phase 1)WithdrawnNCT02786485
What this trial is testing

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphomas+2 more
Bellicum Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT00866762
What this trial is testing

The Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Who this might be right for
Polycythemia VeraEssential Thrombocythemia
Copenhagen University Hospital at Herlev 60
Not applicableEnded earlyNCT00176930
What this trial is testing

Stem Cell Transplant for Hematological Malignancy

Who this might be right for
Leukemia, Myeloid, ChronicAMLLeukemia, Lymphocytic, Acute+6 more
Masonic Cancer Center, University of Minnesota 330
Not applicableUnknownNCT05780411
What this trial is testing

Cancer Survivorship in Hematologic Malignancies

Who this might be right for
Cancer Survivors
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT01816230
What this trial is testing

Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM

Who this might be right for
Hematological MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+1 more
Gamida Cell ltd 36
Not applicableStudy completedNCT00440765
What this trial is testing

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Who this might be right for
Multiple MyelomaHematological Neoplasms
Janssen-Cilag B.V. 331
Early research (Phase 1)UnknownNCT00688116
What this trial is testing

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Synta Pharmaceuticals Corp. 45
Testing effectiveness (Phase 2)Study completedNCT01315132
What this trial is testing

Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesLeukemiaLymphoma+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 47
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Not applicableStudy completedNCT00701844
What this trial is testing

Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

Who this might be right for
LeukemiaAcute LeukemiaAcute Lymphocytic Leukemia+3 more
University of North Carolina, Chapel Hill 315
Not applicableLooking for participantsNCT06829654
What this trial is testing

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

Who this might be right for
SarcomasHaematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 80
Next Page